PIMOZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pimozide, and what generic alternatives are available?
Pimozide is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in PIMOZIDE is pimozide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pimozide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pimozide
A generic version of PIMOZIDE was approved as pimozide by ENDO OPERATIONS on September 28th, 2015.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIMOZIDE?
- What are the global sales for PIMOZIDE?
- What is Average Wholesale Price for PIMOZIDE?
Summary for PIMOZIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 21 |
| Patent Applications: | 5,185 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PIMOZIDE |
| DailyMed Link: | PIMOZIDE at DailyMed |
Recent Clinical Trials for PIMOZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Spaulding Clinical Research LLC | Phase 1 |
| Food and Drug Administration (FDA) | Phase 1 |
| Applied Biology, Inc. | N/A |
Pharmacology for PIMOZIDE
| Drug Class | Typical Antipsychotic |
Medical Subject Heading (MeSH) Categories for PIMOZIDE
Anatomical Therapeutic Chemical (ATC) Classes for PIMOZIDE
US Patents and Regulatory Information for PIMOZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | PIMOZIDE | pimozide | TABLET;ORAL | 204521-001 | Sep 28, 2015 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Endo Operations | PIMOZIDE | pimozide | TABLET;ORAL | 204521-002 | Sep 28, 2015 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
